Browsing Tag
NovoSorb
1 post
Polynovo stock falls as diabetes wound trial results spotlight NovoSorb promise
Polynovo (ASX: PNV) shares slipped 1.37% as NovoSorb diabetes wound trial results showed faster healing in large wounds. Can reimbursement shifts revive growth?